22q11.2缺失综合征的神经生物学视角
本文综述22q11.2缺失综合征作为常见神经精神障碍遗传模型的研究,该缺失与智力障碍、精神分裂症、注意缺陷多动障碍、孤独症谱系障碍、焦虑障碍、癫痫及早发性帕金森病高风险相关。尽管约90%患者共享缺失区域,神经精神表型高度可变,遗传背景、额外罕见致病变异及缺失区域基因调控功能可能是解释因素,对普通人群相关障碍病理生理也有启示。
要点
- 22q11.2缺失综合征是常见神经精神障碍的遗传模型,与精神分裂症等高风险相关。
- 共享缺失区域者神经精神结局高度可变,基因型-表型关联尚未明确。
- 遗传背景、额外罕见致病变异和基因调控功能可能解释表型变异。
核心结论
- 22q11.2缺失综合征作为遗传模型,有助于理解神经精神障碍的病理生理机制,并可能启示普通人群中的常见障碍。
研究设计与样本
- 本文为综述,汇总了关于22q11.2缺失综合征生物学机制的临床前与临床研究。
主要发现
- 22q11.2缺失综合征与智力障碍、精神分裂症、注意缺陷多动障碍、孤独症谱系障碍、焦虑障碍、癫痫及早发性帕金森病的高风险相关。
- 尽管约90%患者共享常见缺失区域,神经精神结局在个体间及生命周期内高度可变,基因型与表型之间的明确关联尚未建立。
- 遗传背景效应、额外罕见致病变异及22q11.2缺失区域部分基因的潜在调控功能可能是解释表型变异的因素。
- 缺失区域多数基因在脑中表达,且遗传诊断可在神经精神障碍出现前早期做出,为早期干预和终身监测提供机会。
临床怎么用
- 对22q11.2缺失综合征个体进行终身监测,可能提供疾病风险与保护因素的重要信息,并支持早期干预。
局限性
- 基因型与表型之间的明确关联尚未建立,表型变异机制仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
22q11.2 deletion syndrome is characterised by a well defined microdeletion that is associated with a high risk of neuropsychiatric disorders, including intellectual disability, schizophrenia, attention-deficit hyperactivity disorder, autism spectrum disorder, anxiety disorders, seizures and epilepsy, and early-onset Parkinson's disease. Preclinical and clinical data reveal substantial variability of the neuropsychiatric phenotype despite the shared underlying deletion in this genetic model. Factors that might explain this variability include genetic background effects, additional rare pathogenic variants, and potential regulatory functions of some genes in the 22q11.2 deletion region. These factors might also be relevant to the pathophysiology of these neuropsychiatric disorders in the general population. We review studies that might provide insight into pathophysiological mechanisms underlying the expression of neuropsychiatric disorders in 22q11.2 deletion syndrome, and potential implications for these common disorders in the general (non-deleted) population. The recurrent hemizygous 22q11.2 deletion, associated with 22q11.2 deletion syndrome, has attracted attention as a genetic model for common neuropsychiatric disorders because of its association with substantially increased risk of such disorders.1 Studying such a model has many advantages. First, 22q11.2 deletion has been genetically well characterised.2 Second, most genes present in the region typically deleted at the 22q11.2 locus are expressed in the brain.3-5 Third, genetic diagnosis might be made early in life, long before recognisable neuropsychiatric disorders have emerged. Thus, this genetic condition offers a unique opportunity for early intervention, and monitoring individuals with 22q11.2 deletion syndrome throughout life could provide important information on factors contributing to disease risk and protection. Despite the commonly deleted region being shared by about 90% of individuals with 22q11.2 deletion syndrome, neuropsychiatric outcomes are highly variable between individuals and across the lifespan. A clear link remains to be established between genotype and phenotype.3,5 In this Review, we summarise preclinical and clinical studies investigating biological mechanisms in 22q11.2 deletion syndrome, with a focus on those that might provide insight into mechanisms underlying neuropsychiatric disorders in 22q11.2 deletion syndrome and in the general population.
引用
- Zinkstok JR, Boot E, Bassett AS, et al. Neurobiological perspective of 22q11.2 deletion syndrome. Lancet Psychiatry. 2019. PMID: 31395526. doi:10.1016/S2215-0366(19)30076-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。